Bladder Cancer New Indication: Erdafitinib in Advanced FGFR Altered Urothelial Cancer Ulas D. Bayraktar, MD 2023-11-20
Bladder Cancer New Indication: Durvalumab with CISplatin and Gemcitabine in Biliary Tract Cancers Ulas D. Bayraktar, MD 2023-06-14
Bladder Cancer New Indication: Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma Ulas D. Bayraktar, MD 2023-06-07
Bladder Cancer New Protocol: Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Cancer Ulas D. Bayraktar, MD 2023-04-14
Bladder Cancer New Reference: Neoadjuvant CISplatin and Gemcitabine for Urothelial Cancer Ulas D. Bayraktar, MD 2023-03-15
